CD8A and cancer: Under normal circumstances, CD8 + T-cell infiltration is a good prognostic factor in patients with cancer; however, it lacks a disadvantage in patients with renal cancer, which might explain why kidney cancer is sensitive to immunotherapy (Kim et al., 2021).